CCA
AGN

Canyon Capital Advisors’s Allergan plc AGN Stock Holding History

Canyon Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-417,697
Closed -$74M – 37
2020
Q1 		$74M Sell
417,697
-587,503
-58% -$111M 2.61% 11
2019
Q4 		$192M Sell
1,005,200
-12,300
-1% -$2.22M 4.48% 9
2019
Q3 		$171M Buy
1,017,500
+767,500
+307% +$125M 3.7% 11
2019
Q2 		$41.9M Buy
+250,000
New +$34.6M 0.85% 26
2018
Q4 		– Sell
-544,361
Closed -$104M – 54
2018
Q3 		$104M Buy
+544,361
New +$100M 1.41% 19
2018
Q2 		– Sell
-816,639
Closed -$137M – 51
2018
Q1 		$137M Buy
816,639
+315,145
+63% +$52.9M 1.39% 16
2017
Q4 		$82M Buy
501,494
+357,559
+248% +$64.2M 1.18% 17
2017
Q3 		$29.5M Sell
143,935
-151,254
-51% -$35.2M 0.44% 23
2017
Q2 		$71.8M Sell
295,189
-4,811
-2% -$1.13M 1.19% 11
2017
Q1 		$71.7M Buy
+300,000
New +$69.9M 1.77% 9

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Canyon Capital Advisors's AGN Position: Q2 2020 in Review

Canyon Capital Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 417,697 shares — an estimated $74M sold.

Canyon Capital Advisors first reported a position in AGN in Q1 2017 and held it in 10 quarters. The position peaked at $192M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Canyon Capital Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Canyon Capital Advisors sold 417,697 Allergan plc shares in Q2 2020, an estimated $74M.
  • Canyon Capital Advisors first reported a position in Allergan plc in Q1 2017 and held it in 10 quarters.
  • Canyon Capital Advisors's Allergan plc position peaked at $192M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Canyon Capital Advisors's 13F filing for Q2 2020, filed 17 Aug 2020.